Fielmann Group AG's yield on cost for the quarter that ended in Mar. 2026 was 0.00.
The historical rank and industry rank for Fielmann Group AG's 5-Year Yield-on-Cost % or its related term are showing as below:
During the past 13 years, Fielmann Group AG's highest Yield on Cost was 5.31. The lowest was 1.52. And the median was 2.62.
XSWX:FIE's 5-Year Yield-on-Cost % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.37 * Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
Fielmann Group AG (XSWX:FIE) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Fielmann Group AG 5-Year Yield-on-Cost % Related Terms
XSWX:FIE vs ISRG, BDX, MDLN: 5-Year Yield-on-Cost % Comparison
For the Medical Instruments & Supplies subindustry, Fielmann Group AG's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fielmann Group AG 5-Year Yield-on-Cost % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Fielmann Group AG's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Fielmann Group AG's 5-Year Yield-on-Cost % falls into.
Fielmann Group AG 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Fielmann Group AG (XSWX:FIE) has a 5-Year Yield-on-Cost % of 0.00 as of Jun. 27, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Fielmann Group AG and its competitors. Over the past decade, Fielmann Group AG's 5-Year Yield-on-Cost % has ranged from 1.52 to 5.31. According to the industry distribution chart, Fielmann Group AG ranks #153 out of 328 companies in the Medical Devices & Instruments industry, placing it in the top 46.6%.
Is Fielmann Group AG's 5-Year Yield-on-Cost % too high?
Fielmann Group AG's current 5-Year Yield-on-Cost % is 0.00. Over the past 10 years, this metric has ranged from a low of 1.52 to a high of 5.31. Based on the distribution chart, Fielmann Group AG ranks #153 out of 328 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Fielmann Group AG has a GF Score™ of 85/100, reflecting its overall financial health beyond just this single metric.
How does Fielmann Group AG's 5-Year Yield-on-Cost % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Fielmann Group AG ranks #153 out of 328 companies for 5-Year Yield-on-Cost %. This puts Fielmann Group AG in the upper half of its industry. The industry median 5-Year Yield-on-Cost % is 2.37. Historically, Fielmann Group AG's own 5-Year Yield-on-Cost % has ranged from 1.52 to 5.31 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Devices & Instruments company?
The median 5-Year Yield-on-Cost % among Medical Devices & Instruments companies is 2.37, based on 328 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Fielmann Group AG and its competitors. For the Medical Devices & Instruments industry, the median 5-Year Yield-on-Cost % is 2.37 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fielmann Group AG's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fielmann Group AG stock overvalued right now?
Fielmann Group AG (XSWX:FIE) has a current 5-Year Yield-on-Cost % of 0.00. The stock's GF Value™ is CHF49.51, compared to a current price of CHF40.45 — trading 18.3% below its estimated fair value. The current 5-Year Yield-on-Cost % is 0.00. Fielmann Group AG's overall GF Score™ is 85/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Fielmann Group AG (XSWX:FIE), the current 5-Year Yield-on-Cost % is 0.00 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fielmann Group AG (XSWX:FIE) Overvalued in 2026?
Based on GuruFocus' analysis, Fielmann Group AG stock appears to be undervalued.
The current stock price of CHF40.45 is trading 18.3% below its estimated GF Value™ of CHF49.51.
Key valuation signals for XSWX:FIE:
5-Year Yield-on-Cost %: 0.00
GF Value™: CHF49.51 vs. price of CHF40.45 (18.3% below fair value)
No single metric tells the full story. See the XSWX:FIE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fielmann Group AG is involved in the purchase and sale of goods, in physical stores as well as wholesale and online, particularly in the optometric and hearing acoustics sectors, and especially sales of all kinds of vision aids - particularly glasses, eyeewear frames and lenses, sunglasses, contact lenses, accessories, hearing systems, as well as personal protective equipment. Fielmann is involved in all levels of the optical industry value-added chain: designing, manufacturing, product offering, and optician services. The group was divided into six segments: Germany, Switzerland, Austria, Spain, North America, and Other. The majority of its revenue is generated from Germany.
85GF Score
Get the complete analysis for XSWX:FIE
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:FIE has been successfully added to your 